Search
for
Sort by
Research 721–750 of 1000+
- Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis
- Benign prostatic hyperplasia and male lower urinary symptoms: A guide for family physicians
- Synthesis and structure–activity studies of side-chain derivatized arylhydantoins for investigation as androgen receptor radioligands
- Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study
- The Influence of Age-Related Cues on Health and Longevity
- Effects of <i>Lespedeza Cuneata aqueous extract</i> on testosterone-induced prostatic hyperplasia
- Safety aspects of androgen treatment with 5α-dihydrotestosterone
- Therapeutic Androgen Receptor Ligands
- Preliminary pharmacokinetics and metabolism of novel non-steroidal antiandrogens in the rat: Relation of their systemic activity to the formation of a common metabolite
- The Effect of Anti-Androgens on the Response of Rat Preputial Glands to Testosterone*
- Antiandrogenic activities of<i>Glycyrrhiza glabra</i>in male rats
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- Screening of synthetic and natural product databases: Identification of novel androgens and antiandrogens
- Finasteride for prostatic disease: an updated and comprehensive review
- New approach to 3-oxo-4-aza-5α-androst-1-ene-17β-(--butylcarboxamide)
- Finasterida: Diez Años De Uso Clínico. Revisión Sistemática De La Literatura
- Practical Geriatrics: Men's Sexual Health After Midlife
- Highly efficient nucleophilic addition of alkyl Grignard reagents to 17-ketosteroids in the presence of cerium(III) chloride: Synthesis of 17α-propyl-17β-hydroxy-4-androsten-3-one, an androgen receptor antagonist
- ANTIANDROGENS AND THE SKIN
- Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency
- Association of Spironolactone Use With Risk of Cancer
- PCPT, MTOPS and the use of 5ARIs: a Canadian consensus regarding implications for clinical practice
- Synthesis and Pharmacological Evaluation of New Progesterone Esters as 5.ALPHA.-Reductase Inhibitors
- Dutasteride‐mediated morphological changes in the genitourinary tract associated with altered expression patterns of the androgen and estrogen receptors in male rats
- Comparison Between Two Different Hamster Models used for the Determination of Testosterone and Finasteride Activity
- Androgen deprivation therapy may constitute a more effective COVID-19 prophylactic than therapeutic strategy
- Dutasteride, a novel dual 5-A reductase inhibitor, reduces serum DHT to a greater extent versus finasteride and achieves finasteride maximal reduction in a larger proportion of patients
- Synthesis and in Vitro Evaluation of 4-Substituted N-(1,1-Dimethylethyl)-3-oxo-4-androstene-17.beta.-carboxamides as 5.alpha.-Reductase Inhibitors and Antiandrogens
- 25 years of ERβ: a personal journey
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases